

| Atlanta, GA, December 29, 2003 | |||||||||||||||||
| Caymus Partners LLC Advises Microtek Medical Holdings, Inc. on the Acquisition of Plasco, Inc. | |||||||||||||||||
|
About Microtek Microtek manufactures infection control products, fluid control products, safety products, and other products to healthcare professionals for use in environments, such as operating rooms and ambulatory surgical centers. The Company’s primary products consist of disposable equipment drapes and specialty patient drapes. Microtek also offers a line of products and supplies used to clean a procedural room; encapsulation products for the management of infectious and hazardous waste, including absorbent powders, which convert infectious liquid waste to a solid form; and disposable compression sleeves used in reducing deep vein thrombosis. Microtek markets its products to hospitals and other end users through distributors and its own direct sales force.About Caymus Partners With offices in Atlanta and New York, Caymus Partners is a leading middle-market investment banking firm, providing merger and acquisition advisory services, private placements and other financial advisory services. Combined, the firm's senior bankers have more than 65 years of experience and have closed over 250 transactions. More information can be found at www.caymuspartners.com. |
|||||||||||||||||
|
3475 Lenox Road, Suite 650
Atlanta, GA 30326
(404) 995-8300
17th Floor
New York, NY 10022
(212) 755-3600
© Caymus Partners LLC
Securities Offered through Caymus Securities LLC, Member FINRA/SIPC
Privacy Policy Business Continuity Plan Important Legal Information



Caymus Partners LLC is pleased to announce that it has advised Microtek Medical Holdings, Inc. (Nasdaq: MTMD) (“Microtek” or the “Company”) on the acquisition of Plasco, Inc., a privately held manufacturer of medical products. Caymus Partners identified over 100 domestic and international acquisition candidates that fit within the Company’s expansion strategy. Caymus Partners conducted detailed due diligence and advised the Company on the appropriate purchase price and consideration for the transaction. Caymus Partners was the exclusive advisor to the Company on the transaction.